Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Implantica AGSTU:8IM1 +2.47%36 Receivables Turnover is 0.00 as of . 20. GuruFocus rates STU:8IM1 with a GF Score™ of 36/100. Among 811 Medical Devices & Instruments companies, Implantica AG ranks worse than 123304.44% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Implantica AG's Revenue for the
six
months ended in . 20 was €0.00 Mil. Implantica AG's average Accounts Receivable for the
six
months ended in . 20 was €0.00 Mil.
Implantica AG (STU:8IM1) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Implantica AG Receivables Turnover Related Terms
Implantica AG Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Implantica AG's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Implantica AG Receivables Turnover Chart
Implantica AG Annual Data
Trend
Receivables Turnover
Implantica AG Semi-Annual Data
Receivables Turnover
STU:8IM1 vs : Receivables Turnover Comparison
For the Medical Devices subindustry, Implantica AG's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Implantica AG Receivables Turnover vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Implantica AG's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Implantica AG's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Implantica AG (STU:8IM1) has a Receivables Turnover of 0.00 as of . 20. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Implantica AG and its competitors. According to the industry distribution chart, Implantica AG ranks #999999 out of 811 companies in the Medical Devices & Instruments industry.
Is Implantica AG's Receivables Turnover too high?
Implantica AG's current Receivables Turnover is 0.00. Based on the distribution chart, Implantica AG ranks #999999 out of 811 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Implantica AG has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does Implantica AG's Receivables Turnover compare to ?
According to the Medical Devices & Instruments industry distribution chart, Implantica AG ranks #999999 out of 811 companies for Receivables Turnover. This places Implantica AG in the lower half of its industry. The industry median Receivables Turnover is 5.51. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Devices & Instruments company?
The median Receivables Turnover among Medical Devices & Instruments companies is 5.51, based on 811 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Implantica AG and its competitors. For the Medical Devices & Instruments industry, the median Receivables Turnover is 5.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Implantica AG's current Receivables Turnover is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Implantica AG stock overvalued right now?
Implantica AG (STU:8IM1) has a current Receivables Turnover of 0.00. The current Receivables Turnover is 0.00. Implantica AG's overall GF Score™ is 36/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Implantica AG (STU:8IM1), the current Receivables Turnover is 0.00 as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Implantica AG is a medtech group providing effective care for serious health conditions and improving patients' quality of life by bringing technology into the body. The therapies Implantica develops are based on implants that are medical devices inserted into the patient's body and are intended to remain in place permanently or semi-permanently, using electrical power provided by a battery. The company has developed a broad, patent-protected product pipeline based partly on its two platform technologies: an eHealth platform designed to monitor a broad range of health parameters, control treatment from inside the body, and communicate with the caregiver at a distance, and a wireless energising platform designed to power remote-controlled implants wirelessly through intact skin.
36GF Score
Get the complete analysis for STU:8IM1
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:8IM1 has been successfully added to your 
